ADD TO SHOPPING CART
IP6 INOSITOL HEXAPHOSPHATE
 $20.95  500 mg  120 caps

IP6 INOSITOL HEXAPHOSPHATE, Cancer Cure, 120 capsules, 500 mg Cancer treatment and free radical damage prevention with Inositol Hexaphosphate (IP6) IP6 Inositol hexaphosphate Supports Natural Cell Defense IP6 contains 500 mg of purified Inositol hexaphosphate (IP6) from brown rice extracted in Japan. IP6 is a phosphorylated form of Inositol commonly found in fiber-rich plant foods. IP6 is hydrolyzed by phytase enzymes in the digestive tract to yield inositol. IP6 supports natural cell defense against damaging hydroxyl free radicals by chelating with reactive iron. Read this Summary of recent clinical studies IP6 May Cut Cancer Risk Up to 70%. IP6 has been shown to shrink cancer tumors in laboratory mice 3 fold in 120 days. Human trials are currently being funded by the National Cancer Institute. Read the latest reports on this research INOSITOL HEXAPHOSPHATE SHOWN TO SHRINK CANCER TUMORS  Supplemental Facts Serving Size: 1 capsule IP6 500 mg (Inositol Hexaphosphate). Other Ingredients: Rice powder and magnesium stearate. Suggested Use: As a dietary supplement, take 1 to 6 capsules per day on an empty stomach, or as directed by your qualified health practitioner. Expiration Date: 2 years from the date of purchase. Brand: Young Again Nutrients. Pharmaceutical grade 120 capsules, 500 mg each. INGREDIENTS IP6 Inositol hexaphosphate, 120 capsules, 500 mg Serving Size : Ingredient Quantity Measure RDA * Inositol Hexaphosphate 500 mg not established * RDA means the Recommended Daily Allowance established by the U.S. Food and Drug Administration. This is the minimum daily amounts of specific essential nutrients necessary for healthy adults 18 year of age. Requirements increase with age and the RDA may be insufficient for older adults or those with poor health IP6 - questions and answers Dr Shamsuddin is Professor of medicine at the University of Maryland School of Medicine in Baltimore USA. Since 1975, he has been researching the process of cancer formation, cancer prevention and cancer treatment. He has pioneered the immune enhancing and anti-cancer actions of IP6 and inositol for which he was awarded the US & European patents. First performed in Dr. Shamsuddin's laboratory, experiments on the anti-cancer action of IP-6 and Inositol have been subsequently reproduced and extended by scientists around the world, reconfirming these fascinating findings. Inositol and IP-6, and the other inositol phosphates i.e. IP-1, IP-2, IP-3, IP-4, IP-5 are normally present in all mammalian cells. IP-3 is a key molecule responsible for cellular signal transduction, controlling vital functions including cell proliferation and differentiation. IP-6 can lose one or more phosphate (P) while inositol can gain them. Thus the combination of IP-6 and Inositol could yield more of the crucial IP-3. The theory is: since i) all cancers, irrespective of their type and origin have a common defect of uncontrolled cell proliferation, ii) IP-3 is a key regulator of cell growth and iii) IP-6 & Inositol yield IP-3, therefore, IP-6 & Inositol should be effective against many a different types of cancers, and across species. The proof can be seen in "About Us" and "What's New." Ongoing research are providing us with new information about these intriguing molecules, almost every day. The Author "IP6: Nature's Revolutionary Cancer Fighter", AbulKalam M. Shamsuddin, MD, PhD, is Professor of Pathology at the University of Maryland School of Medicine in Baltimore. Dr. Shamsuddin graduated from Dhaka Medical College in 1972. Following Internship in Massachusetts and Residency training in pathology in Maryland, he was certified by the American Board of Pathology in 1977. In 1980, he received Ph.D. degree from the University of Maryland for his work on colon carcinogenesis. He joined the faculty of the University of Maryland as an Instructor in 1977, and rose through the ranks of Assistant Professor and Associate Professor to become a full Professor in 1988. For his excellence in teaching, Professor Shamsuddin received the Best Teacher award from the medical students many times, including the coveted "Golden Apple Award" by the American Medical Students' Association in 1999. Dr. Shamsuddin's research on cancer started at the time he began his doctoral dissertation, in 1975. That work was based on his theory of "field effect phenomenon" and resulted in the subsequent invention of a very simple, accurate and practical mass screening test for cancers of the colorectum and lung with potential utility also for cancers of the breast, prostate, uterine cervix, etc. The colorectal cancer test is already popular in China where it is known as "Shams' Test." Dr. Shamsuddin's book on this subject, written for health care professionals is entitled Diagnostic Assays for Colon Cancer [CRC Press, Boca Raton, Florida 1991]. In mid 1985, Dr. Shamsuddin started his pioneering experiments on the anti-cancer property of inositol and inositol hexaphosphate (IP-6).

 **Statements contained herein have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat and cure or prevent disease. Always consult with your professional health care provider before changing any medication.**